These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25768943)

  • 1. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
    Camp EA; Coker AL; Troisi R; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Kaufman RH; Adam E
    J Low Genit Tract Dis; 2008 Apr; 12(2):111-7. PubMed ID: 18369304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
    Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol.
    Camp EA; Robboy SJ; Hatch EE; Titus-Ernstoff LT; Herbst AL; Strohsnitter W; Kaufman RH; Adam E
    J Womens Health (Larchmt); 2012 Feb; 21(2):209-14. PubMed ID: 22150213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in women exposed to diethylstilbestrol in utero.
    Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
    JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
    Laronda MM; Unno K; Butler LM; Kurita T
    Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D; Anderson D; Palmer JR; Herbst AL
    Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and management of DES-exposed women.
    Vieiralves-Wiltgen C; Engle VF
    Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.